Moderna is seeking emergency use authorization for an updated shot targeting the BA.4 and BA.5 subtypes of the omicron variant for children between the ages of 6 and 17, the company said in a tweet Friday. Moderna plans to seek clearance for its Omicron-targeting booster for children 6 months to 5 years later this year.
Updated boosters from Moderna and partners
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.